![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 1-(4-((4-(dimethylamino)piperidin-1-yl)carbonyl)phenyl)-3-(4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl)urea
2. Pf-05212384
3. Pki 587
4. Pki-587
5. Pki587
1. 1197160-78-3
2. Pki-587
3. Pf-05212384
4. Pki 587
5. 1-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea
6. Pki587
7. Pf-05212384 (pki-587)
8. Pf 05212384
9. Chembl592445
10. 1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
11. 96265tnh2r
12. N-[4-[[4-(dimethylamino)-1-piperidinyl]carbonyl]phenyl]-n'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea
13. Gedatolisib (pf-05212384, Pki-587)
14. Pki-587; Pf-05212384
15. Urea, N-(4-((4-(dimethylamino)-1-piperidinyl)carbonyl)phenyl)-n'-(4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl)-
16. 1-(4-((4-(dimethylamino)piperidin-1-yl)carbonyl)phenyl)-3-(4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl)urea
17. Gedatolisib [usan:inn]
18. Unii-96265tnh2r
19. 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
20. Urea, N-[4-[[4-(dimethylamino)-1-piperidinyl]carbonyl]phenyl]-n'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-
21. Pk 587
22. Pk 1587
23. Gedatolisib(pki-587)
24. Gedatolisib [inn]
25. Gedatolisib (usan/inn)
26. Gedatolisib [usan]
27. Gedatolisib (pki-587)
28. Schembl32393
29. Gedatolisib [who-dd]
30. Gtpl7940
31. Dtxsid40152557
32. Ex-a028
33. Hms3748m11
34. Bcp01986
35. Bdbm50308135
36. Mfcd16875679
37. Nsc758256
38. Nsc801014
39. S2628
40. Zinc49757175
41. Akos005766013
42. Ccg-264662
43. Cs-0449
44. Db11896
45. Fe-0013
46. Nsc-758256
47. Nsc-801014
48. Sb16571
49. Ncgc00370777-01
50. Ncgc00370777-04
51. Ac-31519
52. Hy-10681
53. Ft-0700110
54. Pki-587,pf-05212384
55. A25474
56. D10635
57. J-004182
58. J-523339
59. Q27077788
60. Pki-587
61. 1197160-78-3
62. Pki587
63. Pki 587
64. N-(4-((4-(dimethylamino)-1-piperidinyl)carbonyl)phenyl)-n'-(4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl)urea
65. N-[4-[[4-(dimethylamino)-1-piperidinyl]carbonyl]phenyl]-n'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]urea
66. N-{4-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]phenyl}-n'-{4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl}urea
67. Vl1
Molecular Weight | 615.7 g/mol |
---|---|
Molecular Formula | C32H41N9O4 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 7 |
Exact Mass | 615.32815082 g/mol |
Monoisotopic Mass | 615.32815082 g/mol |
Topological Polar Surface Area | 128 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 913 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)